- Home
- ATRA vs BAFN Comparison
ATRA vs BAFN Comparison
Compare ATRA & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- BAFN
- Stock Information
- Founded
- ATRA 2012
- BAFN 1999
- Country
- ATRA United States
- BAFN United States
- Employees
- ATRA N/A
- BAFN N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- BAFN Savings Institutions
- Sector
- ATRA Health Care
- BAFN Finance
- Exchange
- ATRA Nasdaq
- BAFN Nasdaq
- Market Cap
- ATRA 50.3M
- BAFN 55.9M
- IPO Year
- ATRA 2014
- BAFN N/A
- Fundamental
- Price
- ATRA $10.61
- BAFN $12.98
- Analyst Decision
- ATRA Hold
- BAFN
- Analyst Count
- ATRA 5
- BAFN 0
- Target Price
- ATRA $26.88
- BAFN N/A
- AVG Volume (30 Days)
- ATRA 143.9K
- BAFN 8.7K
- Earning Date
- ATRA 11-12-2024
- BAFN 10-24-2024
- Dividend Yield
- ATRA N/A
- BAFN 2.37%
- EPS Growth
- ATRA N/A
- BAFN N/A
- EPS
- ATRA N/A
- BAFN 0.73
- Revenue
- ATRA $100,439,000.00
- BAFN $76,217,000.00
- Revenue This Year
- ATRA $1,190.80
- BAFN N/A
- Revenue Next Year
- ATRA N/A
- BAFN N/A
- P/E Ratio
- ATRA N/A
- BAFN $18.08
- Revenue Growth
- ATRA 2111.34
- BAFN 7.06
- 52 Week Low
- ATRA $6.50
- BAFN $10.15
- 52 Week High
- ATRA $39.50
- BAFN $15.05
- Technical
- Relative Strength Index (RSI)
- ATRA 51.14
- BAFN 40.68
- Support Level
- ATRA $11.10
- BAFN $13.46
- Resistance Level
- ATRA $14.93
- BAFN $15.05
- Average True Range (ATR)
- ATRA 1.46
- BAFN 0.57
- MACD
- ATRA -0.14
- BAFN -0.05
- Stochastic Oscillator
- ATRA 24.48
- BAFN 32.41
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About BAFN BayFirst Financial Corp.
BayFirst Financial Corp is a one bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios.